SK Biopharmaceuticals Co., Ltd. (KOSE: A326030)
Health Care · Pharmaceuticals · KR
₩75,800.00
-0.13% today · -27.0% 1Y
SK Biopharmaceuticals Co., Ltd. (KOSE: A326030) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.41B.
Over the last twelve months the share price has lost 27.0%, trading between 73.00K and 144.10K.
Tweenvest scores SK Biopharmaceuticals Co., Ltd. across four factors: quality 74/100, value 66/100, growth 100/100. Its strongest factor is growth.
A326030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.41B
- Revenue (TTM)
- $556.20M
- P/E
- 14.80
- EPS
- 5,119.90
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- ₩144,100.00
- 52-week low
- ₩73,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 78.31M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.66B | CN¥27.74 | +9.64% |
| Ajanta Pharma LimitedNSEI: AJANTPHARM | $4.65B | Rs3,581.00 | +0.94% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.59B | ¥1,613.50 | +1.16% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.54B | £16.07 | -2.37% |
| Dottikon ES Holding AGSWX: DESN | $4.38B | CHF256.50 | -3.02% |
| Dong-E-E-Jiao Co., Ltd.SZSE: 000423 | $4.37B | CN¥45.95 | +1.57% |
| Changchun High-Tech Industry (Group) Co., Ltd.SZSE: 000661 | $4.30B | CN¥71.83 | +1.81% |
| Edgewise Therapeutics, Inc.NasdaqGS: EWTX | $4.30B | $39.23 | -0.86% |
Figures last refreshed Oct 4, 2026.